The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 772K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

14 articles for EA Kowaluk


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
4
Emerging molecular approaches to pain therapy.EBI
Abbott Laboratories
8
 
Synthesis of phosphorus-containing amino acid analogs as inhibitors of nitric oxide synthaseEBI
TBA
59
4-amino-5-aryl-6-arylethynylpyrimidines: structure-activity relationships of non-nucleoside adenosine kinase inhibitors.EBI
Abbott Laboratories
14
Synthesis and biological evaluation of pteridine and pyrazolopyrimidine based adenosine kinase inhibitors.EBI
Abbott Laboratories
23
5,6,7-trisubstituted 4-aminopyrido[2,3-d]pyrimidines as novel inhibitors of adenosine kinase.EBI
Abbott Laboratories
15
Adenosine kinase inhibitors: polar 7-substitutent of pyridopyrimidine derivatives improving their locomotor selectivity.EBI
Abbott Laboratories
26
Design, synthesis, and structure-activity relationship of 6-alkynylpyrimidines as potent adenosine kinase inhibitors.EBI
Abbott Laboratories
8
Pyridopyrimidine analogues as novel adenosine kinase inhibitors.EBI
Abbott Laboratories
21
Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor..EBI
Abbott Laboratories
33
Structure-activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors.EBI
Abbott Laboratories
5
Design of adenosine kinase inhibitors from the NMR-based screening of fragments.EBI
Abbott Laboratories
23
Nitroaromatic amino acids as inhibitors of neuronal nitric oxide synthase.EBI
Abbott Laboratories
354
Primary carboxamides as BTK inhibitorsBDB
Abbvie
17
Design, synthesis, and X-ray crystal structures of 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors.BDB
Duquesne University